 | • レポートコード：GIR-2104Z04308 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、デビック病治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。デビック病治療薬の種類別市場規模（グルココルチコイド、免疫グロブリン、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・デビック病治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Fresenius、TEVA、Sandoz、Intas、Gyjtrs、Nang Kuang、Tianjin Kingyork、Baxter、CSL、Grifols、Octapharma、CBOP ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：グルココルチコイド、免疫グロブリン、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・デビック病治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・デビック病治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・デビック病治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・デビック病治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・デビック病治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Devic’s Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Devic’s Disease Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Devic’s Disease Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Devic’s Disease Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Glucocorticoids
Immunoglobulin
Other
Market segment by Application can be divided into
Hospitals
Clinics
Others
The key market players for global Devic’s Disease Drug market are listed below:
Pfizer
Fresenius
TEVA
Sandoz
Intas
Gyjtrs
Nang Kuang
Tianjin Kingyork
Baxter
CSL
Grifols
Octapharma
CBOP
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Devic’s Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Devic’s Disease Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Glucocorticoids
1.2.3 Immunoglobulin
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Devic’s Disease Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Devic’s Disease Drug Market Size & Forecast
1.4.1 Global Devic’s Disease Drug Sales in Value (2016-2026))
1.4.2 Global Devic’s Disease Drug Sales in Volume (2016-2026)
1.4.3 Global Devic’s Disease Drug Price by Type (2016-2026) & (USD/MT)
1.5 Global Devic’s Disease Drug Production Capacity Analysis
1.5.1 Global Devic’s Disease Drug Total Production Capacity (2016-2026)
1.5.2 Global Devic’s Disease Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Devic’s Disease Drug Market Drivers
1.6.2 Devic’s Disease Drug Market Restraints
1.6.3 Devic’s Disease Drug Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Devic’s Disease Drug Product and Services
2.1.4 Pfizer Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Fresenius
2.2.1 Fresenius Details
2.2.2 Fresenius Major Business
2.2.3 Fresenius Devic’s Disease Drug Product and Services
2.2.4 Fresenius Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 TEVA
2.3.1 TEVA Details
2.3.2 TEVA Major Business
2.3.3 TEVA Devic’s Disease Drug Product and Services
2.3.4 TEVA Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sandoz
2.4.1 Sandoz Details
2.4.2 Sandoz Major Business
2.4.3 Sandoz Devic’s Disease Drug Product and Services
2.4.4 Sandoz Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Intas
2.5.1 Intas Details
2.5.2 Intas Major Business
2.5.3 Intas Devic’s Disease Drug Product and Services
2.5.4 Intas Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Gyjtrs
2.6.1 Gyjtrs Details
2.6.2 Gyjtrs Major Business
2.6.3 Gyjtrs Devic’s Disease Drug Product and Services
2.6.4 Gyjtrs Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Nang Kuang
2.7.1 Nang Kuang Details
2.7.2 Nang Kuang Major Business
2.7.3 Nang Kuang Devic’s Disease Drug Product and Services
2.7.4 Nang Kuang Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Tianjin Kingyork
2.8.1 Tianjin Kingyork Details
2.8.2 Tianjin Kingyork Major Business
2.8.3 Tianjin Kingyork Devic’s Disease Drug Product and Services
2.8.4 Tianjin Kingyork Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Baxter
2.9.1 Baxter Details
2.9.2 Baxter Major Business
2.9.3 Baxter Devic’s Disease Drug Product and Services
2.9.4 Baxter Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 CSL
2.10.1 CSL Details
2.10.2 CSL Major Business
2.10.3 CSL Devic’s Disease Drug Product and Services
2.10.4 CSL Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Grifols
2.11.1 Grifols Details
2.11.2 Grifols Major Business
2.11.3 Grifols Devic’s Disease Drug Product and Services
2.11.4 Grifols Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Octapharma
2.12.1 Octapharma Details
2.12.2 Octapharma Major Business
2.12.3 Octapharma Devic’s Disease Drug Product and Services
2.12.4 Octapharma Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 CBOP
2.13.1 CBOP Details
2.13.2 CBOP Major Business
2.13.3 CBOP Devic’s Disease Drug Product and Services
2.13.4 CBOP Devic’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Devic’s Disease Drug Sales by Manufacturer
3.1 Global Devic’s Disease Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Devic’s Disease Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Devic’s Disease Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Devic’s Disease Drug Manufacturer Market Share
3.4.2 Top 6 Devic’s Disease Drug Manufacturer Market Share
3.5 Global Devic’s Disease Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Devic’s Disease Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Devic’s Disease Drug Market Size by Region
4.1.1 Global Devic’s Disease Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Devic’s Disease Drug Revenue by Region (2016-2026)
4.2 North America Devic’s Disease Drug Revenue (2016-2026)
4.3 Europe Devic’s Disease Drug Revenue (2016-2026)
4.4 Asia-Pacific Devic’s Disease Drug Revenue (2016-2026)
4.5 South America Devic’s Disease Drug Revenue (2016-2026)
4.6 Middle East and Africa Devic’s Disease Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Devic’s Disease Drug Sales in Volume by Type (2016-2026)
5.2 Global Devic’s Disease Drug Revenue by Type (2016-2026)
5.3 Global Devic’s Disease Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Devic’s Disease Drug Sales in Volume by Application (2016-2026)
6.2 Global Devic’s Disease Drug Revenue by Application (2016-2026)
6.3 Global Devic’s Disease Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Devic’s Disease Drug Sales by Type (2016-2026)
7.2 North America Devic’s Disease Drug Sales by Application (2016-2026)
7.3 North America Devic’s Disease Drug Market Size by Country
7.3.1 North America Devic’s Disease Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Devic’s Disease Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Devic’s Disease Drug Sales by Type (2016-2026)
8.2 Europe Devic’s Disease Drug Sales by Application (2016-2026)
8.3 Europe Devic’s Disease Drug Market Size by Country
8.3.1 Europe Devic’s Disease Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Devic’s Disease Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Devic’s Disease Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Devic’s Disease Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Devic’s Disease Drug Market Size by Region
9.3.1 Asia-Pacific Devic’s Disease Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Devic’s Disease Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Devic’s Disease Drug Sales by Type (2016-2026)
10.2 South America Devic’s Disease Drug Sales by Application (2016-2026)
10.3 South America Devic’s Disease Drug Market Size by Country
10.3.1 South America Devic’s Disease Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Devic’s Disease Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Devic’s Disease Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Devic’s Disease Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Devic’s Disease Drug Market Size by Country
11.3.1 Middle East & Africa Devic’s Disease Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Devic’s Disease Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Devic’s Disease Drug Typical Distributors
12.3 Devic’s Disease Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Devic's Disease Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Devic's Disease Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Devic's Disease Drug Product and Services
Table 6. Pfizer Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Fresenius Basic Information, Manufacturing Base and Competitors
Table 8. Fresenius Major Business
Table 9. Fresenius Devic's Disease Drug Product and Services
Table 10. Fresenius Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. TEVA Basic Information, Manufacturing Base and Competitors
Table 12. TEVA Major Business
Table 13. TEVA Devic's Disease Drug Product and Services
Table 14. TEVA Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sandoz Basic Information, Manufacturing Base and Competitors
Table 16. Sandoz Major Business
Table 17. Sandoz Devic's Disease Drug Product and Services
Table 18. Sandoz Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Intas Basic Information, Manufacturing Base and Competitors
Table 20. Intas Major Business
Table 21. Intas Devic's Disease Drug Product and Services
Table 22. Intas Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Gyjtrs Basic Information, Manufacturing Base and Competitors
Table 24. Gyjtrs Major Business
Table 25. Gyjtrs Devic's Disease Drug Product and Services
Table 26. Gyjtrs Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Nang Kuang Basic Information, Manufacturing Base and Competitors
Table 28. Nang Kuang Major Business
Table 29. Nang Kuang Devic's Disease Drug Product and Services
Table 30. Nang Kuang Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Tianjin Kingyork Basic Information, Manufacturing Base and Competitors
Table 32. Tianjin Kingyork Major Business
Table 33. Tianjin Kingyork Devic's Disease Drug Product and Services
Table 34. Tianjin Kingyork Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Baxter Basic Information, Manufacturing Base and Competitors
Table 36. Baxter Major Business
Table 37. Baxter Devic's Disease Drug Product and Services
Table 38. Baxter Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. CSL Basic Information, Manufacturing Base and Competitors
Table 40. CSL Major Business
Table 41. CSL Devic's Disease Drug Product and Services
Table 42. CSL Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Grifols Basic Information, Manufacturing Base and Competitors
Table 44. Grifols Major Business
Table 45. Grifols Devic's Disease Drug Product and Services
Table 46. Grifols Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Octapharma Basic Information, Manufacturing Base and Competitors
Table 48. Octapharma Major Business
Table 49. Octapharma Devic's Disease Drug Product and Services
Table 50. Octapharma Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. CBOP Basic Information, Manufacturing Base and Competitors
Table 52. CBOP Major Business
Table 53. CBOP Devic's Disease Drug Product and Services
Table 54. CBOP Devic's Disease Drug Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Devic's Disease Drug Sales by Manufacturer (2019-2021e) & (K MT)
Table 56. Global Devic's Disease Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Devic's Disease Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Devic's Disease Drug Production Capacity by Company, (K MT): 2020 VS 2021
Table 59. Head Office and Devic's Disease Drug Production Site of Key Manufacturer
Table 60. Global Devic's Disease Drug Sales by Region (2016-2021e) & (K MT)
Table 61. Global Devic's Disease Drug Sales by Region (2021-2026) & (K MT)
Table 62. Global Devic's Disease Drug Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Devic's Disease Drug Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Devic's Disease Drug Sales by Type (2016-2021e) & (K MT)
Table 65. Global Devic's Disease Drug Sales by Type (2021-2026) & (K MT)
Table 66. Global Devic's Disease Drug Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Devic's Disease Drug Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Devic's Disease Drug Price by Type (2016-2021e) & (USD/MT)
Table 69. Global Devic's Disease Drug Price by Type (2021-2026) & (USD/MT)
Table 70. Global Devic's Disease Drug Sales by Application (2016-2021e) & (K MT)
Table 71. Global Devic's Disease Drug Sales by Application (2021-2026) & (K MT)
Table 72. Global Devic's Disease Drug Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Devic's Disease Drug Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Devic's Disease Drug Price by Application (2016-2021e) & (USD/MT)
Table 75. Global Devic's Disease Drug Price by Application (2021-2026) & (USD/MT)
Table 76. North America Devic's Disease Drug Sales by Country (2016-2021e) & (K MT)
Table 77. North America Devic's Disease Drug Sales by Country (2021-2026) & (K MT)
Table 78. North America Devic's Disease Drug Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Devic's Disease Drug Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Devic's Disease Drug Sales by Type (2016-2021e) & (K MT)
Table 81. North America Devic's Disease Drug Sales by Type (2021-2026) & (K MT)
Table 82. North America Devic's Disease Drug Sales by Application (2016-2021e) & (K MT)
Table 83. North America Devic's Disease Drug Sales by Application (2021-2026) & (K MT)
Table 84. Europe Devic's Disease Drug Sales by Country (2016-2021e) & (K MT)
Table 85. Europe Devic's Disease Drug Sales by Country (2021-2026) & (K MT)
Table 86. Europe Devic's Disease Drug Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Devic's Disease Drug Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Devic's Disease Drug Sales by Type (2016-2021e) & (K MT)
Table 89. Europe Devic's Disease Drug Sales by Type (2021-2026) & (K MT)
Table 90. Europe Devic's Disease Drug Sales by Application (2016-2021e) & (K MT)
Table 91. Europe Devic's Disease Drug Sales by Application (2021-2026) & (K MT)
Table 92. Asia-Pacific Devic's Disease Drug Sales by Region (2016-2021e) & (K MT)
Table 93. Asia-Pacific Devic's Disease Drug Sales by Region (2021-2026) & (K MT)
Table 94. Asia-Pacific Devic's Disease Drug Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Devic's Disease Drug Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Devic's Disease Drug Sales by Type (2016-2021e) & (K MT)
Table 97. Asia-Pacific Devic's Disease Drug Sales by Type (2021-2026) & (K MT)
Table 98. Asia-Pacific Devic's Disease Drug Sales by Application (2016-2021e) & (K MT)
Table 99. Asia-Pacific Devic's Disease Drug Sales by Application (2021-2026) & (K MT)
Table 100. South America Devic's Disease Drug Sales by Country (2016-2021e) & (K MT)
Table 101. South America Devic's Disease Drug Sales by Country (2021-2026) & (K MT)
Table 102. South America Devic's Disease Drug Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Devic's Disease Drug Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Devic's Disease Drug Sales by Type (2016-2021e) & (K MT)
Table 105. South America Devic's Disease Drug Sales by Type (2021-2026) & (K MT)
Table 106. South America Devic's Disease Drug Sales by Application (2016-2021e) & (K MT)
Table 107. South America Devic's Disease Drug Sales by Application (2021-2026) & (K MT)
Table 108. Middle East & Africa Devic's Disease Drug Sales by Country (2016-2021e) & (K MT)
Table 109. Middle East & Africa Devic's Disease Drug Sales by Country (2021-2026) & (K MT)
Table 110. Middle East & Africa Devic's Disease Drug Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Devic's Disease Drug Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Devic's Disease Drug Sales by Type (2016-2021e) & (K MT)
Table 113. Middle East & Africa Devic's Disease Drug Sales by Type (2021-2026) & (K MT)
Table 114. Middle East & Africa Devic's Disease Drug Sales by Application (2016-2021e) & (K MT)
Table 115. Middle East & Africa Devic's Disease Drug Sales by Application (2021-2026) & (K MT)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Devic's Disease Drug Typical Distributors
Table 119. Devic's Disease Drug Typical Customers
List of Figures
Figure 1. Devic's Disease Drug Picture
Figure 2. Global Devic's Disease Drug Sales Market Share by Type in 2020
Figure 3. Glucocorticoids
Figure 4. Immunoglobulin
Figure 5. Other
Figure 6. Global Devic's Disease Drug Sales Market Share by Application in 2020
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Others
Figure 10. Global Devic's Disease Drug Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 11. Global Devic's Disease Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Devic's Disease Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Devic's Disease Drug Sales (2016-2026) & (K MT)
Figure 32. Global Devic's Disease Drug Production Capacity (2016-2026) & (K MT)
Figure 33. Global Devic's Disease Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Devic's Disease Drug Market Drivers
Figure 35. Devic's Disease Drug Market Restraints
Figure 36. Devic's Disease Drug Market Trends
Figure 37. Global Devic's Disease Drug Sales Market Share by Manufacturer in 2020
Figure 38. Global Devic's Disease Drug Revenue Market Share by Manufacturer in 2020
Figure 39. Devic's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Devic's Disease Drug Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Devic's Disease Drug Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Devic's Disease Drug Sales Market Share by Region (2016-2026)
Figure 43. Global Devic's Disease Drug Revenue Market Share by Region (2016-2026)
Figure 44. North America Devic's Disease Drug Revenue (2016-2026) & (USD Million)
Figure 45. Europe Devic's Disease Drug Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Devic's Disease Drug Revenue (2016-2026) & (USD Million)
Figure 47. South America Devic's Disease Drug Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Devic's Disease Drug Revenue (2016-2026) & (USD Million)
Figure 49. Global Devic's Disease Drug Sales Market Share by Type (2016-2026)
Figure 50. Global Devic's Disease Drug Revenue Market Share by Type (2016-2026)
Figure 51. Global Devic's Disease Drug Price by Type (2016-2026) & (USD/MT)
Figure 52. Global Devic's Disease Drug Sales Market Share by Application (2016-2026)
Figure 53. Global Devic's Disease Drug Revenue Market Share by Application (2016-2026)
Figure 54. Global Devic's Disease Drug Price by Application (2016-2026) & (USD/MT)
Figure 55. North America Devic's Disease Drug Sales Market Share by Country (2016-2026)
Figure 56. North America Devic's Disease Drug Revenue Market Share by Country (2016-2026)
Figure 57. North America Devic's Disease Drug Sales Market Share by Type (2016-2026)
Figure 58. North America Devic's Disease Drug Sales Market Share by Application (2016-2026)
Figure 59. Europe Devic's Disease Drug Sales Market Share by Country (2016-2026)
Figure 60. Europe Devic's Disease Drug Revenue Market Share by Country (2016-2026)
Figure 61. Europe Devic's Disease Drug Sales Market Share by Type (2016-2026)
Figure 62. Europe Devic's Disease Drug Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Devic's Disease Drug Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Devic's Disease Drug Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Devic's Disease Drug Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Devic's Disease Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Devic's Disease Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Devic's Disease Drug Revenue Market Share by Country (2016-2026)
Figure 69. South America Devic's Disease Drug Sales Market Share by Type (2016-2026)
Figure 70. South America Devic's Disease Drug Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Devic's Disease Drug Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Devic's Disease Drug Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Devic's Disease Drug Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Devic's Disease Drug Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の牛高山病治療薬市場規模・現状・予測（2021年-2027年） Bovine high-mountain disease (BHMD) is also known as brisket disease which causes significant death loss, especially in calves. The bovine high-mountain disease is right heart failure which is generally caused due to hypoxic pulmonary hypertension at high altitudes. Market Analysis and Insights: Glo…- 世界の牛高山病治療薬市場規模・現状・予測（2021年-2027年） Bovine high-mountain disease (BHMD) is also known as brisket disease which causes significant death loss, especially in calves. The bovine high-mountain disease is right heart failure which is generally caused due to hypoxic pulmonary hypertension at high altitudes. Market Analysis and Insights: Glo…
- 世界のパーキンソン病治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Parkinson Disease Drug Market The global Parkinson Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…
- 世界の椎間板変性症治療市場規模・現状・予測（2021年-2027年） Degenerative Disc Disease refers to symptoms of back or neck pain caused by wear and tear on a spinal disc. Market Analysis and Insights: Global Degenerative Disc Disease Treatment Market The global Degenerative Disc Disease Treatment market size is projected to reach US$ XX million by 2026, from US…
- 世界の代謝性疾患治療市場規模・現状・予測（2021年-2027年） Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc. Market Analysis and Insights: Global Metabolic Disease Treatment Market The global Metabolic Disease Treatment market size is projected to reach US$ XX million…